These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 32307830)
1. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway. Han L; Yan Y; Zhao L; Liu Y; Lv X; Zhang L; Zhao Y; Zhao H; He M; Wei M J Cell Mol Med; 2020 Jun; 24(11):6242-6252. PubMed ID: 32307830 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-148a-3p suppresses epithelial-to-mesenchymal transition and stemness properties via Wnt1-mediated Wnt/β-catenin pathway in pancreatic cancer. Fu X; Hong L; Yang Z; Tu Y; Xin W; Zha M; Tu S; Sun G; Li Y; Xiao W J Cell Mol Med; 2020 Nov; 24(22):13020-13035. PubMed ID: 33026174 [TBL] [Abstract][Full Text] [Related]
3. LncCCAT1 Promotes Breast Cancer Stem Cell Function through Activating WNT/β-catenin Signaling. Tang T; Guo C; Xia T; Zhang R; Zen K; Pan Y; Jin L Theranostics; 2019; 9(24):7384-7402. PubMed ID: 31695775 [No Abstract] [Full Text] [Related]
4. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway. Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA HOTTIP promotes the metastatic potential of ovarian cancer through the regulation of the miR-615-3p/SMARCE1 pathway. Wu H; Wei HY; Chen QQ Kaohsiung J Med Sci; 2020 Dec; 36(12):973-982. PubMed ID: 32783402 [TBL] [Abstract][Full Text] [Related]
6. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2. Chen Y; Wu N; Liu L; Dong H; Liu X J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224 [TBL] [Abstract][Full Text] [Related]
7. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2. Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway. Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of lncRNA HOTTIP Inhibits Retinoblastoma Progression by Modulating the miR-101-3p/STC1 Axis. Yuan X; Sun Z; Cui C Technol Cancer Res Treat; 2021; 20():1533033821997831. PubMed ID: 33784880 [TBL] [Abstract][Full Text] [Related]
10. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α. Wang M; Zhao HY; Zhang JL; Wan DM; Li YM; Jiang ZX Exp Cell Res; 2020 Nov; 396(1):112280. PubMed ID: 32961145 [TBL] [Abstract][Full Text] [Related]
11. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo. Shi J; Tan S; Song L; Song L; Wang Y Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA RP11-283G6.5 confines breast cancer development through modulating miR-188-3p/TMED3/Wnt/β-catenin signalling. Pei J; Zhang S; Yang X; Han C; Pan Y; Li J; Wang Z; Sun C; Zhang J RNA Biol; 2021 Oct; 18(sup1):287-302. PubMed ID: 34130584 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b. Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744 [TBL] [Abstract][Full Text] [Related]
14. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs. Guo X; Liu Y; Zheng X; Han Y; Cheng J Life Sci; 2020 May; 248():117445. PubMed ID: 32081664 [TBL] [Abstract][Full Text] [Related]
15. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Fu Z; Chen C; Zhou Q; Wang Y; Zhao Y; Zhao X; Li W; Zheng S; Ye H; Wang L; He Z; Lin Q; Li Z; Chen R Cancer Lett; 2017 Dec; 410():68-81. PubMed ID: 28947139 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. Lu G; Li Y; Ma Y; Lu J; Chen Y; Jiang Q; Qin Q; Zhao L; Huang Q; Luo Z; Huang S; Wei Z J Exp Clin Cancer Res; 2018 Nov; 37(1):289. PubMed ID: 30482236 [TBL] [Abstract][Full Text] [Related]
17. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro. Tang Y; Yang P; Zhu Y; Su Y Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis. Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G; Wang K J Cell Physiol; 2019 Nov; 234(11):20816-20828. PubMed ID: 31012108 [TBL] [Abstract][Full Text] [Related]
19. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis. Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375 [TBL] [Abstract][Full Text] [Related]
20. LncRNA HOXA11-AS promotes migration and invasion through modulating miR-148a/WNT1/β-catenin pathway in gastric cancer. Guo T; Yuan X; Liu DF; Peng SH; Xu AM Neoplasma; 2020 May; 67(3):492-500. PubMed ID: 32009419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]